APHRIA - Technical Analysis
Updated
Dear Traders,
Today I'm having a look at APH, As we can see we had a retracement going on for a week, and it's price now hit the 200 EMA on the 4H chart. this happened before and it created a nice bounce. The question is, will this support level hold again? My guess? Yes. Look at that continuing BUllish divergence in the MACD, this shows us something will happen soon, and it's bullish. Perfect entry point would be the 200 ema.
APHRIA NEWS: Aphria To Announce First Quarter Results On October 12, 2018 => Keep on eye on the charts that day, good news could bring more vol. - Source: web.tmxmoney.com/article.php?newsid=7329810142652013&qm_symbol=APH
ABOUT APH:
Aphria Inc is licensed to produce and sell medical marijuana, including dried cannabis and cannabis oil, as a Licensed Producer under the provisions of the ACMPR.
Today I'm having a look at APH, As we can see we had a retracement going on for a week, and it's price now hit the 200 EMA on the 4H chart. this happened before and it created a nice bounce. The question is, will this support level hold again? My guess? Yes. Look at that continuing BUllish divergence in the MACD, this shows us something will happen soon, and it's bullish. Perfect entry point would be the 200 ema.
APHRIA NEWS: Aphria To Announce First Quarter Results On October 12, 2018 => Keep on eye on the charts that day, good news could bring more vol. - Source: web.tmxmoney.com/article.php?newsid=7329810142652013&qm_symbol=APH
ABOUT APH:
Aphria Inc is licensed to produce and sell medical marijuana, including dried cannabis and cannabis oil, as a Licensed Producer under the provisions of the ACMPR.
Trade active
APH is hungry ! now let's see if that 55 ema will be a hard resistance to break, in my opinion bulls well get blocked at first, but if the buying vol is big enough we could see another run to break that 55 ema !Note
Still fighting for that 55 ema !Note
RUN APH ! BE FREEEENote
''Marlboro maker Altria in talks with pot grower Aphria''
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.